Table 5.
COVID-19 vaccine status (Number of doses and duration since last dose) | Unadjusted ORa (95% CI) | P-Value | Adjusted for age ORa (95% CI) | P-Value | Adjusted for comorbidities ORa (95% CI) | P-Value | Adjusted for Age and comorbidities ORa (95% CI) | P-Value |
---|---|---|---|---|---|---|---|---|
Asymptomatic vs Hospitalisation | ||||||||
Unvaccinated | 1.0 | 1.0 | 1.0 | 1.0 | ||||
One dose taken in less than14 days of symptoms onset | 0.76 (0.27–2.11) | 0.596 | 0.57 (0.19–1.68) | 0.307 | 0.74 (0.26–2.08) | 0.571 | 0.57 (0.19–1.68) | 0.310 |
One dose taken in more than14 days of symptoms onset | 0.24 (0.08–0.73) | 0.012 | 0.25 (0.08–0.79) | 0.018 | 0.24 (0.08–0.73) | 0.012 | 0.24 (0.08–0.79) | 0.019 |
Second dose taken in less than14 days of symptoms onset | 0.19 (0.04–0.89) | 0.035 | 0.18 (0.04–0.86) | 0.031 | 0.19 (0.04–0.85) | 0.030 | 0.17 (0.04–0.83) | 0.029 |
Second dose taken in more than14 days of symptoms onset | 0.14 (0.04–0.49) | 0.002 | 0.13 (0.03–0.46) | 0.002 | 0.13 (0.04–0.47) | 0.002 | 0.12 (0.03–0.45) | 0.002 |
Asymptomatic vs ICU/Death | ||||||||
Unvaccinated | 1.0 | 1.0 | 1.0 | 1.0 | ||||
One dose taken in less than14 days of symptoms onset | 0.56 (0.19–1.64) | 0.290 | 0.37 (0.11–1.26) | 0.113 | 0.56 (0.19–1.63) | 0.282 | 0.38 (0.11–1.27) | 0.282 |
One dose taken in more than14 days of symptoms onset | 0.47 (0.20–1.10) | 0.081 | 0. 46 (0.17–1.29) | 0.141 | 0.47 (0.19–1.09) | 0.080 | 0.47 (0.17–1.29) | 0.080 |
Second dose taken in less than14 days of symptoms onset | 0.09 (0.01–0.67) | 0.019 | 0.07 (0.01–0.64) | 0.019 | 0.08 (0.01–0.65) | 0.018 | 0.07 (0.01–0.65) | 0.020 |
Second dose taken in more than14 days of symptoms onset | 0.08 (0.02–0.36) | 0.001 | 0.07 (0.01–0.35) | 0.001 | 0.08 (0.02–0.35) | 0.001 | 0.07 (0.01–0.36) | 0.001 |
OR: odds ratio.